• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    6/2/22 1:27:44 PM ET
    $ACOR
    $ADN
    $AERI
    $AFIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ACOR alert in real time by email

     

    During the Thursday's session, 100 stocks hit new 52-week lows.

    Areas of Significance In Today's 52-Week Lows:

    • Medtronic (NYSE:MDT) was the largest firm by market cap to set a new 52-week low.
    • Acorda Therapeutics (NASDAQ:ACOR) was the smallest company by market cap to set a new 52-week low.
    • Immunic (NASDAQ:IMUX)'s stock moved significantly downwards, trading down 43.14% to reach a new 52-week low.
    • Sutro Biopharma (NASDAQ:STRO) was the most promising stock of the group, with shares actually trading up 0.0% to bounce back after reaching its new 52-week low.

    On Thursday, the following stocks set new 52-week lows:

    • Medtronic (NYSE:MDT) shares were up 0.44% for the day, having made a 52-week low of $96.12.
    • Healthpeak Properties (NYSE:PEAK) shares hit a yearly low of $28.55. The stock was down 1.5% on the session.
    • James Hardie Industries (NYSE:JHX) stock drifted down 0.56% on Thursday morning to hit a new 52-week low of $24.44.
    • Ciena (NYSE:CIEN) shares set a new yearly low of $46.60 this morning. The stock was down 5.0% on the session.
    • Carvana (NYSE:CVNA) shares reached a new 52-week low of $25.31 on Thursday morning, moving up 6.08%.
    • Empire State Realty OP (NYSE:FISK) shares were down 5.16% for the day, having made a 52-week low of $7.41.
    • PTC Therapeutics (NASDAQ:PTCT) shares were down 3.71% for the day, having made a 52-week low of $27.05.
    • Canopy Gwth (NASDAQ:CGC) shares reached a new 52-week low of $4.56 on Thursday morning, moving up 1.17%.
    • Xencor (NASDAQ:XNCR) stock set a new 52-week low of $21.08 on Thursday, moving down 1.33%.
    • Celldex Therapeutics (NASDAQ:CLDX) shares set a new 52-week low of $21.68. The stock traded down 2.42%.
    • Iovance Biotherapeutics (NASDAQ:IOVA) stock hit a yearly low of $6.18. The stock was up 1.02% for the day.
    • Community Health Systems (NYSE:CYH) shares hit a yearly low of $4.96. The stock was up 0.45% on the session.
    • Big Lots (NYSE:BIG) shares were up 3.58% for the day, having made a 52-week low of $22.29.
    • Bright Green (NASDAQ:BGXX) stock hit a new 52-week low of $3.31. The stock was up 13.0% on the session.
    • Gladstone Land (NASDAQ:LANDM) stock drifted down 0.16% on Thursday morning to hit a new 52-week low of $25.15.
    • PMV Pharma (NASDAQ:PMVP) shares were up 4.26% for the day, having made a 52-week low of $11.19.
    • Coherus BioSciences (NASDAQ:CHRS) shares set a new yearly low of $7.01 this morning. The stock was down 2.38% on the session.
    • RCI Hospitality Holdings (NASDAQ:RICK) stock broke to a new 52-week low of $49.50 on Thursday. Shares of the company traded up 2.94%.
    • AnaptysBio (NASDAQ:ANAB) shares hit a yearly low of $18.20. The stock was down 2.22% on the session.
    • MVB Financial (NASDAQ:MVBF) stock hit a yearly low of $36.35. The stock was down 0.33% for the day.
    • Inhibrx (NASDAQ:INBX) shares set a new yearly low of $10.92 this morning. The stock was down 0.71% on the session.
    • Innovid (NYSE:CTV) stock set a new 52-week low of $2.99 on Thursday, moving down 12.43%.
    • D-MARKET Electronic (NASDAQ:HEPS) stock hit a yearly low of $1.17. The stock was down 3.63% for the day.
    • Ouster (NYSE:OUST) shares fell to $2.01 on Thursday, setting a new 52-week low with a shift of up 2.96%.
    • OrganiGram Holdings (NASDAQ:OGI) shares set a new yearly low of $1.08 this morning. The stock was up 2.7% on the session.
    • BARK (NYSE:BARK) shares set a new 52-week low of $1.90. The stock traded down 5.73%.
    • Cepton (NASDAQ:CPTN) shares made a new 52-week low of $2.26 on Thursday. The stock was down 2.55% for the day.
    • LexinFintech Holdings (NASDAQ:LX) stock hit a new 52-week low of $1.84. The stock was down 0.26% on the session.
    • Centessa Pharmaceuticals (NASDAQ:CNTA) stock hit a new 52-week low of $3.59. The stock was down 19.67% on the session.
    • SeaSpine Holdings (NASDAQ:SPNE) shares hit a yearly low of $7.61. The stock was down 0.38% on the session.
    • Oaktree Acquisition (NYSE:OACB) shares were down 8.13% for the day, having made a 52-week low of $8.96.
    • Conn's (NASDAQ:CONN) stock hit a new 52-week low of $11.15. The stock was down 10.14% on the session.
    • Aerie Pharmaceuticals (NASDAQ:AERI) stock achieved a new 52-week low on Thursday morning, hitting $4.81 and moving up 2.83%.
    • Fathom Digital Mfg (NYSE:FATH) stock achieved a new 52-week low on Thursday morning, hitting $4.66 and moving down 1.87%.
    • Dyne Therapeutics (NASDAQ:DYN) shares made a new 52-week low of $4.30 on Thursday. The stock was up 2.05% for the day.
    • Airspan Networks Hldgs (AMEX:MIMO) shares fell to $2.15 on Thursday, setting a new 52-week low with a shift of up 4.33%.
    • bluebird bio (NASDAQ:BLUE) stock hit $2.87 on Thursday morning, setting a new 52-week low for a change of up 1.18%.
    • Macrogenics (NASDAQ:MGNX) stock set a new 52-week low of $3.26 on Thursday, moving up 0.3%.
    • POET Technologies (NASDAQ:POET) shares hit a yearly low of $5.32. The stock was up 2.77% on the session.
    • Sutro Biopharma (NASDAQ:STRO) shares fell to $4.13 on Thursday, setting a new 52-week low with a shift of 0.0% (flat).
    • Jounce Therapeutics (NASDAQ:JNCE) shares reached a new 52-week low of $3.59 on Thursday morning, moving up 1.37%.
    • Viking Therapeutics (NASDAQ:VKTX) stock hit $2.10 on Thursday morning, setting a new 52-week low for a change of up 1.41%.
    • Personalis (NASDAQ:PSNL) stock hit a new 52-week low of $3.51. The stock was up 0.97% on the session.
    • XBiotech (NASDAQ:XBIT) stock achieved a new 52-week low on Thursday morning, hitting $5.18 and moving up 4.61%.
    • BYND Cannasoft Enterprise (NASDAQ:BCAN) stock hit $4.05 on Thursday morning, setting a new 52-week low for a change of down 7.22%.
    • First Community (NASDAQ:FCCO) shares hit a yearly low of $18.01. The stock was down 0.76% on the session.
    • United Security (NASDAQ:UBFO) shares set a new 52-week low of $7.24. The stock traded down 1.49%.
    • NeuroPace (NASDAQ:NPCE) shares set a new 52-week low of $4.90. The stock traded down 1.62%.
    • Paratek Pharmaceuticals (NASDAQ:PRTK) shares set a new yearly low of $1.60 this morning. The stock was up 0.8% on the session.
    • So-Young Intl (NASDAQ:SY) stock hit a yearly low of $0.95. The stock was up 1.04% for the day.
    • Electric Last Mile Solns (NASDAQ:ELMS) stock hit a yearly low of $0.56. The stock was down 1.48% for the day.
    • Advent Technologies Hldgs (NASDAQ:ADN) stock drifted up 6.15% on Thursday morning to hit a new 52-week low of $1.26.
    • Centogene (NASDAQ:CNTG) shares reached a new 52-week low of $2.56 on Thursday morning, moving down 8.57%.
    • Kirkland's (NASDAQ:KIRK) stock broke to a new 52-week low of $4.75 on Thursday. Shares of the company traded down 3.99%.
    • Atreca (NASDAQ:BCEL) shares set a new yearly low of $1.51 this morning. The stock was down 3.77% on the session.
    • BioVie (NASDAQ:BIVI) shares were down 1.71% for the day, having made a 52-week low of $2.25.
    • Codiak BioSciences (NASDAQ:CDAK) shares were up 1.2% for the day, having made a 52-week low of $2.48.
    • Visionary Education Tech (NASDAQ:VEDU) shares set a new 52-week low of $1.33. The stock traded down 6.12%.
    • iBio (AMEX:IBIO) stock dropped to a yearly low on Thursday of $0.22. Shares traded down 0.57%.
    • Elevation Oncology (NASDAQ:ELEV) shares made a new 52-week low of $2.08 on Thursday. The stock was down 2.76% for the day.
    • Athenex (NASDAQ:ATNX) stock hit a new 52-week low of $0.42. The stock was down 2.45% on the session.
    • Aquestive Therapeutics (NASDAQ:AQST) stock hit a new 52-week low of $0.95. The stock was down 1.75% on the session.
    • Sera Prognostics (NASDAQ:SERA) shares were down 2.27% for the day, having made a 52-week low of $1.28.
    • Helbiz (NASDAQ:HLBZ) stock hit $0.91 on Thursday morning, setting a new 52-week low for a change of down 0.95%.
    • Spero Therapeutics (NASDAQ:SPRO) stock hit $1.03 on Thursday morning, setting a new 52-week low for a change of down 3.57%.
    • Renovacor (AMEX:RCOR) shares hit a yearly low of $1.68. The stock was down 7.18% on the session.
    • T2 Biosystems (NASDAQ:TTOO) shares hit a yearly low of $0.19. The stock was down 2.9% on the session.
    • TRACON Pharma (NASDAQ:TCON) shares reached a new 52-week low of $1.60 on Thursday morning, moving down 1.62%.
    • Regis (NYSE:RGS) stock broke to a new 52-week low of $0.67 on Thursday. Shares of the company traded down 0.58%.
    • Cumberland (NASDAQ:CPIX) shares reached a new 52-week low of $1.99 on Thursday morning, moving down 4.78%.
    • Lixiang Education Hldg (NASDAQ:LXEH) stock hit a new 52-week low of $1.90. The stock was down 8.09% on the session.
    • Assure Hldgs (NASDAQ:IONM) stock set a new 52-week low of $1.55 on Thursday, moving down 7.54%.
    • Medigus (NASDAQ:MDGS) stock hit a yearly low of $0.78. The stock was up 1.22% for the day.
    • Panbela Therapeutics (NASDAQ:PBLA) stock dropped to a yearly low on Thursday of $1.44. Shares traded down 0.19%.
    • Acutus Medical (NASDAQ:AFIB) shares set a new yearly low of $0.61 this morning. The stock was down 3.22% on the session.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) stock dropped to a yearly low on Thursday of $0.60. Shares traded down 5.36%.
    • WiSA Technologies (NASDAQ:WISA) stock broke to a new 52-week low of $0.63 on Thursday. Shares of the company traded down 13.87%.
    • Sharps Technology (NASDAQ:STSS) stock hit a yearly low of $1.03. The stock was down 1.83% for the day.
    • Histogen (NASDAQ:HSTO) stock achieved a new 52-week low on Thursday morning, hitting $0.13 and moving down 12.21%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $ADN
    $AERI
    $AFIB

    CompanyDatePrice TargetRatingAnalyst
    Iovance Biotherapeutics Inc.
    $IOVA
    2/25/2026$5.00Mkt Perform → Mkt Outperform
    Citizens
    Centessa Pharmaceuticals plc
    $CNTA
    2/24/2026$40.00Outperform
    Wolfe Research
    Medtronic plc.
    $MDT
    2/13/2026$116.00Overweight
    Barclays
    MVB Financial Corp.
    $MVBF
    2/13/2026$31.00 → $33.00Outperform
    Hovde Group
    James Hardie Industries plc.
    $JHX
    2/11/2026Neutral → Overweight
    Analyst
    Medtronic plc.
    $MDT
    2/9/2026$121.00Hold → Buy
    Needham
    First Community Corporation
    $FCCO
    2/3/2026$32.00 → $34.00Outperform
    Hovde Group
    Medtronic plc.
    $MDT
    2/3/2026$117.00Buy
    Citigroup
    More analyst ratings

    $ACOR
    $ADN
    $AERI
    $AFIB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Reynolds E. Leland bought $14,835 worth of shares (500 units at $29.67), increasing direct ownership by 2% to 30,930 units (SEC Form 4)

    4 - FIRST COMMUNITY CORP /SC/ (0000932781) (Issuer)

    2/2/26 3:49:56 PM ET
    $FCCO
    Major Banks
    Finance

    Director Cordella Richard James Jr bought $13,850 worth of Common Stock (500 units at $27.70) (SEC Form 4)

    4 - MVB FINANCIAL CORP (0001277902) (Issuer)

    12/8/25 11:04:59 AM ET
    $MVBF
    Major Banks
    Finance

    Chief Financial Officer Sumbs Michael Robert bought $52,000 worth of Common Stock (2,000 units at $26.00) (SEC Form 4)

    4 - MVB FINANCIAL CORP (0001277902) (Issuer)

    11/5/25 3:16:16 PM ET
    $MVBF
    Major Banks
    Finance

    $ACOR
    $ADN
    $AERI
    $AFIB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Iovance Biotherapeutics upgraded by Citizens with a new price target

    Citizens upgraded Iovance Biotherapeutics from Mkt Perform to Mkt Outperform and set a new price target of $5.00

    2/25/26 7:38:09 AM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Wolfe Research initiated coverage on Centessa Pharmaceuticals with a new price target

    Wolfe Research initiated coverage of Centessa Pharmaceuticals with a rating of Outperform and set a new price target of $40.00

    2/24/26 7:47:48 AM ET
    $CNTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays resumed coverage on Medtronic with a new price target

    Barclays resumed coverage of Medtronic with a rating of Overweight and set a new price target of $116.00

    2/13/26 8:31:53 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    SEC Filings

    View All

    iBio Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - iBio, Inc. (0001420720) (Filer)

    2/27/26 4:49:58 PM ET
    $IBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3 filed by iBio Inc.

    S-3 - iBio, Inc. (0001420720) (Filer)

    2/27/26 4:23:59 PM ET
    $IBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by James Hardie Industries plc.

    6-K - James Hardie Industries plc (0001159152) (Filer)

    2/27/26 11:08:10 AM ET
    $JHX
    Building Materials
    Industrials

    $ACOR
    $ADN
    $AERI
    $AFIB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Bvf Partners L P/Il claimed ownership of 7,590,690 shares (SEC Form 3)

    3 - IMMUNIC, INC. (0001280776) (Issuer)

    2/27/26 5:03:09 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Nagel Robert Thorvald

    3 - IMMUNIC, INC. (0001280776) (Issuer)

    2/27/26 5:00:26 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Crapps Michael C was granted 7,762 shares and covered exercise/tax liability with 3,572 shares, increasing direct ownership by 6% to 76,025 units (SEC Form 4)

    4 - FIRST COMMUNITY CORP /SC/ (0000932781) (Issuer)

    2/26/26 6:28:59 PM ET
    $FCCO
    Major Banks
    Finance

    $ACOR
    $ADN
    $AERI
    $AFIB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026

    - Sustained off-treatment efficacy despite barzolvolimab clearance and normalization of tryptase, suggesting disease modification in patients with CSU treated for full 52 weeks -- Greatly improved quality of life and reduced disease impact for patients with ColdU/SD at Week 20 -HAMPTON, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) presented additional positive data from the completed Phase 2 clinical trials of barzolvolimab in chronic spontaneous urticaria (CSU) and cold urticaria (ColdU) and symptomatic dermographism (SD). Barzolvolimab is a humanized monoclonal antibody with a completely novel mechanism of action that uniquely targets the root cause of CSU, ColdU and SD—

    2/27/26 2:45:00 PM ET
    $CLDX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Carvana to Present at Upcoming Morgan Stanley Technology, Media & Telecom Conference

    Carvana (NYSE:CVNA), a leading e-commerce platform for buying and selling cars, today announced that Ernie Garcia, Carvana's Founder and Chief Executive Officer, will present to the investor community and host meetings at the upcoming Morgan Stanley Technology, Media & Telecom Conference. Morgan Stanley Technology, Media & Telecom Conference Presentation Date and Time: Monday, March 2, 2026, at 12:20 PM PT* *A webcast of the presentation will be accessible on the Investor Relations section of the Carvana website (https://investors.carvana.com). An archived replay of the webcast will be available following the live presentation. About Carvana Carvana's mission is to change the way pe

    2/27/26 8:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    MacroGenics to Participate in Upcoming Investor Conferences

    ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company's management team will participate in the following investor conferences in March: TD Cowen 46th Annual Health Care Conference (Boston, MA). MacroGenics' President and CEO, Eric Risser, will participate in a hybrid presentation and fireside chat on Tuesday, March 3, at 3:10 pm ET. MacroGenics' management will also participate in one-on-one meetings.Leerink Partners 2026 Global Healthcare Conference (Miami, FL). Mr. Risser will participate in a fireside chat on

    2/26/26 5:30:00 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Leadership Updates

    Live Leadership Updates

    View All

    MVB Financial Names Dr. Kelly Nelson Chairman of the Board of Directors; Appoints Adam Famularo New Director

    The Board of Directors of MVB Financial Corp. ("MVBF" or "MVB Financial") (NASDAQ:MVBF), today announced that Dr. Kelly R. Nelson has been named Chairman of the Board and announced the appointment of Adam Famularo as a Member of the Board, effective February 17, 2026. Dr. Nelson Assumes Chairman Role Dr. Nelson, who has been a member of the Board since 2004, replaces retiring Chairman W. Marston "Marty" Becker. "Dr. Nelson brings a combination of medical expertise, business acumen and deep community commitment to his new role as Chairman," said Larry F. Mazza, CEO and President, MVB Financial. "His experience makes him uniquely suited for this leadership role. Dr. Nelson previously ch

    2/18/26 4:30:00 PM ET
    $MVBF
    Major Banks
    Finance

    Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

    Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm™ New Drug Application (NDA) to the United Stated Food and Drug Admi

    2/18/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Financials

    Live finance-specific insights

    View All

    Hepsiburada Announces Fourth Quarter and Full Year 2025 Financial Results

    ISTANBUL, Türkiye, Feb. 27, 2026 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services & Trading (d/b/a "Hepsiburada") (NASDAQ:HEPS), a leading Turkish e-commerce platform (referred to herein as "Hepsiburada" or the "Company"), today announces its unaudited financial results for the fourth quarter and for the full year ended December 31, 2025. Restatement of financial information: Pursuant to the International Accounting Standard 29, Financial Reporting in Hyperinflationary Economies ("IAS 29"), the financial statements of entities whose functional currency is that of a hyperinflationary economy must be adjusted for the effects of changes in a general price index. Turkish companies reporting u

    2/26/26 5:00:00 PM ET
    $HEPS
    Catalog/Specialty Distribution
    Consumer Discretionary

    CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®

    NASHVILLE, Tenn., Feb. 25, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, today announced the launch of its national sales promotional for Talicia®.  Cumberland has assumed responsibility for the distribution and sales promotion of the brand in the U.S. under the co-commercialization agreement with RedHill Biopharma. Talicia is an FDA-approved oral capsule indicated for the treatment of Helicobacter pylori infection in adults, a bacterial infection and leading risk factor for gastric cancer. Talicia is the only all-in-one treatment containing omeprazole, amoxicillin and rifabutin and

    2/25/26 7:00:00 AM ET
    $CPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE

    NASHVILLE, Tenn., Feb. 24, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company, announced today that it will release its 2025 financial results and provide a company update after the market closes on Tuesday, March 3, 2026. A conference call will be held on March 3 at 4:30 p.m. Eastern Time to discuss the results and update.The link to register is https://register-conf.media-server.com/register/BI6effc1a9cae9445f9bb0d60817870ffa.Once registered, participants can dial in from their phone using a dial-in and PIN number that will be provided to them. Alternatively, they can choose a "Call Me" option to have the system automatically call them at

    2/24/26 4:05:00 PM ET
    $CPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $ADN
    $AERI
    $AFIB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care